ribociclib in early breast cancer | nejm
Published 3 months ago • 1.2K plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:26:06
nejm dialogues -- breast cancer
-
1:39
frontline endocrine therapies and ribociclib in early stage hr her2- breast cancer
-
1:41
adapt trial: endocrine ribociclib vs. chemotherapy in hr /her2- early breast cancer
-
2:23
natalee: ribociclib nsai as adjuvant treatment in patients with hr /her2− early breast cancer
-
0:38
inclusion criteria for natalee trial - evaluating importance of ajuvant ribociclib #oncology #cancer
-
1:48
natalee and monarche: ribociclib and abemaciclib in hr /her2- breast cancer
-
1:26
ribecca: ribociclib, a cdk4/6 inhibitor in er breast cancer
-
3:08
adding ribociclib to endocrine therapy shows an improvement in invasive dfs in hr /her2 bc patients
-
2:05
palbociclib and letrozole for advanced breast cancer
-
7:14
ribociclib for hr advanced breast cancer
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
1:11
using ribociclib in the first-line setting
-
0:36
maintenance w/ et ribociclib after 1l chemotherapy in hr /her2- metastatic breast cancer
-
8:24
monaleesa-7 trial in premenopausal hr breast cancer
-
3:46
harmonia clinical trial
-
13:54
overall survival results from monaleesa-2: endocrine therapy and ribociclib in hr positive and h...
-
7:23
study of ribociclib and pdr001 in hr metastatic breast cancer
-
1:19
monaleesa-2: improved os seen in hr advanced breast cancer treated with ribociclib letrozole